Endocrine Abstracts

Objective: To study the baseline characteristics predicting hypogonadotropic hypogonadism (HH) persistence in men with macroprolactinoma following medical treatment with cabergoline.Design: Retrospective cohort study conducted in a tertiary pituitary center.Methods: Male patients diagnosed with macroprolactinoma and HH that received cabergoline treatment with subsequent prolactin normalization were included: men that achieved eugon...

Objective: To study the outcomeof menwith macroprolactinoma followingcabergoline treatment based on tumor size.Design: A retrospective cohort study using a single tertiary referral center registry.Methods: The study included 96 men with macroprolctinoma, aged 16–84 years (mean 47.3 years) treated from 1993 to 2019,for a mean follow-up of 7.5 years. The cohort was subdivided into 3 groups according to baseline adenoma diameter...